8 Best Online GLP-1 Programs Ranked [2026]

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence.

Finding the best online GLP-1 program in 2026 is harder than it should be. The market has exploded — dozens of telehealth platforms now offer prescriptions for semaglutide and tirzepatide, and it can be nearly impossible to tell the legitimate programs from the ones cutting corners. Prices vary by hundreds of dollars per month. Oversight ranges from thorough to almost nonexistent.

This guide ranks eight telehealth platforms based on price, medical legitimacy, program structure, and real-world results reported by users and supported by clinical context. Whether you're looking for the cheapest semaglutide online or the most comprehensive care, you'll find an honest breakdown here.

how GLP-1 medications work for weight loss

How We Evaluated These Programs

Before diving into the rankings, here's exactly how The GLP-1 Guide Team assessed each platform. We applied a consistent scoring framework across five categories:

1. Medical Legitimacy (25 points)

Does the platform employ licensed prescribers (MDs, DOs, NPs, or PAs)?
Is there a real clinical intake process, including a health history review?
Are lab tests required or offered before prescribing?
Is there ongoing clinical oversight, or is it a one-time prescription?

2. Medication Options and Quality (20 points)

Do they offer FDA-approved brand-name GLP-1s, compounded versions, or both?
Is compounded semaglutide sourced from an FDA-registered 503B or reputable 503A pharmacy?
Are dosing protocols evidence-based and gradual (to minimize side effects)?

3. Cost Transparency (20 points)

Is pricing clearly displayed before you sign up?
Are there hidden fees (labs, consultations, shipping)?
Are there financial assistance options or manufacturer savings programs?

4. Program Support (20 points)

Is nutritional coaching, behavioral support, or fitness guidance included?
How responsive is customer support?
What happens if you experience side effects?

5. User Experience and Access (15 points)

How fast can you get an appointment?
Is the app or portal easy to use?
Are prescriptions sent to your preferred pharmacy, or only through the platform?

We also reviewed publicly available user feedback, platform terms of service, and the regulatory status of affiliated pharmacies where disclosed. We did not receive payment from any platform in exchange for rankings.

The 8 Best GLP-1 Programs Ranked

1. Hims & Hers — Best Overall for Affordability + Access

Monthly cost: ~$199–$299 (compounded semaglutide); varies for brand-name options Medication offered: Compounded semaglutide, compounded tirzepatide; brand-name referrals Rx oversight: Licensed prescribers in all 50 states

Hims & Hers built its reputation on accessible telehealth at scale, and its GLP-1 program reflects that. The intake process is thorough — you complete a detailed health history, and a licensed clinician reviews your case before any prescription is issued. Compounded semaglutide is sourced from 503A-licensed compounding pharmacies and shipped directly to your door.

What stands out: Transparent pricing (posted online before signup), a clear titration schedule, and a responsive support team. The platform also includes basic nutritional guidance with the program.

What to watch: Like most compounding-focused platforms, the clinical relationship is primarily asynchronous. If you want regular video check-ins, you may need to request them specifically.

Score: 87/100

2. WeightWatchers (Sequence) — Best for Behavioral Support Integration

Monthly cost: ~$99–$149 (membership + coaching, medication billed separately at market rate) Medication offered: Compounded and brand-name GLP-1s; insurance support assistance Rx oversight: Board-certified physicians and NPs

WeightWatchers relaunched its clinical arm (formerly Sequence) as a fully integrated weight management program combining GLP-1 prescribing with behavioral coaching, nutrition tracking, and community support. This is the closest thing to a "whole person" approach available in telehealth format.

What stands out: Active insurance navigation support — the platform employs staff who help you find out if your plan covers GLP-1s and assist with prior authorization appeals. This is rare and valuable. According to the platform's published data, approximately 60% of members who pursue insurance coverage are ultimately approved.

What to watch: Monthly membership fees apply on top of medication costs, which can add up. The app can feel overwhelming for people who just want a prescription without the full lifestyle program.

Score: 84/100

3. Ro Body — Best for Streamlined Experience

Monthly cost: ~$145–$299 (program fee); medication costs vary Medication offered: Compounded semaglutide; brand-name options via insurance Rx oversight: Licensed physicians and NPs

Ro Body offers a clean, well-designed telehealth experience. The onboarding is fast — most patients receive a prescriber decision within 24 hours. Compounded semaglutide is dispensed through Ro's affiliated pharmacy, which is FDA-registered.

What stands out: Ro includes metabolic lab testing as part of the program, not as an add-on. This adds real clinical value and helps identify any underlying conditions (like thyroid issues) that might affect your results.

What to watch: Less flexibility in pharmacy choice compared to some competitors — medications are dispensed through Ro's own pharmacy network.

Score: 82/100

4. Noom Med — Best for Psychology-First Approach

Monthly cost: ~$149–$199 (Noom subscription) + medication costs billed separately Medication offered: Brand-name GLP-1s (with insurance support); compounded options available Rx oversight: Licensed physicians with behavioral health integration

Noom has long built its brand around the psychology of eating behavior. Noom Med adds GLP-1 prescribing to that foundation. Rather than treating the medication as the sole intervention, Noom treats it as one tool within a broader behavioral change program.

What stands out: If sustainable habit change matters to you — not just weight loss while on the drug, but long-term maintenance — Noom's behavior-focused curriculum is among the best in the telehealth space. Research published in the Journal of Clinical Endocrinology & Metabolism suggests that combining GLP-1 therapy with behavioral counseling produces better long-term weight maintenance outcomes than medication alone.

What to watch: The layered subscription model (Noom app + Noom Med) can be confusing and more expensive than it first appears. Make sure you understand exactly what you're paying for at each tier.

Score: 80/100

5. Found — Best for Personalized Medication Matching

Monthly cost: ~$99 membership + medication costs (varies by prescription) Medication offered: GLP-1s and non-GLP-1 medications (bupropion, naltrexone, metformin); compounded options Rx oversight: Board-certified physicians

Found differentiates itself by not defaulting every patient to a GLP-1. Their intake process evaluates whether a GLP-1 is actually the right fit — or whether another FDA-cleared medication might serve you better based on your health history.

What stands out: Thoughtful matching process. If you're someone who has had GI issues in the past or doesn't qualify for semaglutide/tirzepatide, Found can still match you with a clinically appropriate weight management medication. This patient-first approach feels meaningfully different from platforms where everyone gets the same default prescription.

What to watch: The broader medication menu means the GLP-1 offering is not as specialized. If you specifically want the most comprehensive GLP-1 support, this may not be your top choice.

Score: 78/100

6. LifeMD (Shapiro MD) — Best for Low-Cost Entry Point

Monthly cost: ~$129–$199 (compounded semaglutide programs) Medication offered: Compounded semaglutide; tirzepatide in select states Rx oversight: Licensed prescribers in all 50 states

LifeMD operates several health brands under one umbrella, and its GLP-1 offering through its weight management division is one of the more affordable options with a genuine clinical backbone. The intake process is mostly asynchronous, but prescribers are licensed and review each case individually.

What stands out: Competitive pricing for compounded semaglutide, with a clear titration schedule and dosage adjustments included in the program fee. Customer service responsiveness is above average based on user-reported feedback.

What to watch: The program support layer is thinner than competitors like WeightWatchers or Noom Med. You're largely managing lifestyle changes on your own. The platform also markets aggressively, so vet the specifics before committing.

Score: 74/100

7. Calibrate — Best for Metabolic Health Focus

Monthly cost: ~$149–$250/month (one-year commitment typically required) Medication offered: Brand-name GLP-1s (insurance-first model); compounded options added in 2025 Rx oversight: Board-certified physicians with specialist access

Calibrate built its program around the concept of "metabolic health" — using GLP-1 therapy alongside food, sleep, exercise, and emotional health coaching. The four-pillar model is clinically informed and reflects current evidence that lifestyle factors significantly impact GLP-1 outcomes.

What stands out: Calibrate coordinates with your insurance and pursues prior authorization aggressively. If you have insurance that might cover GLP-1s, Calibrate is among the best at navigating that process.

What to watch: The one-year commitment model has historically frustrated users who wanted to stop or pause. Check the current cancellation policy carefully before enrolling. The program is best suited to people who want deep engagement, not just a prescription.

Score: 73/100

8. Henry Meds — Best for Compounded Tirzepatide Access

Monthly cost: ~$297–$399/month (tirzepatide programs) Medication offered: Compounded semaglutide and compounded tirzepatide Rx oversight: Licensed prescribers; all-virtual model

Henry Meds focuses almost exclusively on hormone and metabolic health, and its GLP-1 program is notable for reliable access to compounded tirzepatide — a formulation that is harder to find at other platforms following the FDA's evolving guidance on tirzepatide compounding in 2025.

What stands out: If tirzepatide is your target medication (clinical trials showed an average weight reduction of up to 20.9% over 72 weeks in the SURMOUNT-1 trial), Henry Meds is one of the few platforms still actively offering a compounded version with a legitimate pharmacy partnership.

What to watch: Higher price point for the tirzepatide program. Minimal lifestyle coaching included. This is a prescription-focused service, not a lifestyle program.

Score: 71/100

Comparison Table

Use this table for a side-by-side view of all eight platforms. Prices reflect 2026 market rates and may change.

Platform	Medication Offered	Monthly Cost Range	Best For	Our Score
Hims & Hers	Compounded semaglutide/tirzepatide; brand referrals	$199–$299	Affordability + access	87/100
WeightWatchers (Sequence)	Compounded + brand-name; insurance support	$99–$149 (+ med cost)	Behavioral support + insurance navigation	84/100
Ro Body	Compounded semaglutide; brand via insurance	$145–$299	Streamlined experience + labs included	82/100
Noom Med	Brand-name (primary); compounded available	$149–$199 (+ med cost)	Psychology-first / habit change	80/100
Found	GLP-1s + non-GLP-1 options; compounded	$99 (+ med cost)	Personalized medication matching	78/100
LifeMD	Compounded semaglutide; tirzepatide (select states)	$129–$199	Budget-conscious entry point	74/100
Calibrate	Brand-name (primary); compounded added 2025	$149–$250	Metabolic health + insurance pursuit	73/100
Henry Meds	Compounded semaglutide + tirzepatide	$297–$399	Compounded tirzepatide access	71/100

Prices are estimates based on publicly available information as of early 2026. Always verify current pricing on the platform's website before enrolling.

how to get insurance to cover Wegovy or Ozempic

Compounded vs. Brand-Name GLP-1: What You Need to Know in 2026

This is one of the most important topics to understand before choosing a program — and one of the most misunderstood.

What Is Compounded Semaglutide?

Compounded semaglutide is a version of the same active ingredient found in Wegovy and Ozempic, prepared by a licensed compounding pharmacy rather than manufactured by Novo Nordisk (which recently received an FDA warning letter). During periods of drug shortage, the FDA permitted compounding pharmacies to produce semaglutide under specific conditions.

The FDA declared the semaglutide shortage resolved in late 2024. This triggered a regulatory shift: 503B outsourcing facilities were required to stop producing compounded semaglutide for bulk distribution by a specific compliance deadline in early 2025, while 503A pharmacies (which compound for individual patient prescriptions) continue to operate under state pharmacy board oversight.

As of 2026, the regulatory landscape for compounded semaglutide is actively evolving. The practical upshot:

503B compounding (bulk production): Largely phased out for semaglutide; check whether your telehealth platform's pharmacy is still operating legally
503A compounding (patient-specific): Still available in many states; compounded for individual patients by licensed pharmacies
Brand-name (Wegovy, Ozempic, Mounjaro, Zepbound): FDA-approved; manufacturer quality controls in place; significantly more expensive without insurance

Are Compounded GLP-1s Safe?

Compounded medications are not FDA-approved in the same way brand-name drugs are. They have not undergone the same clinical trials. However, when produced by a licensed, reputable 503A or 503B pharmacy using pharmaceutical-grade ingredients, they use the same active ingredient (semaglutide or tirzepatide).

The FDA has issued warnings about counterfeit and low-quality compounded GLP-1 products. According to the FDA's MedWatch reporting, adverse events linked to compounded semaglutide products — many from unvetted sources — increased substantially in 2023–2024.

What to look for in a legitimate compounded program:

The pharmacy is licensed and in good standing with its state board
The platform discloses which pharmacy it uses
Medications include a certificate of analysis (COA) confirming ingredient purity
A real prescriber reviews your case before any prescription is issued

Brand-Name GLP-1 Cost Reality

Without insurance, brand-name GLP-1s remain prohibitively expensive for most patients:

Wegovy (semaglutide 2.4 mg): ~$1,349/month list price (as of 2026, direct-to-consumer pricing available from $349/month via TrumpRx and Novo Nordisk programs); Novo Nordisk savings programs can reduce this to $0–$25/month for commercially insured patients
Zepbound (tirzepatide): ~$1,059/month list price; Eli Lilly's savings card available for eligible patients
Ozempic (semaglutide 1.0 mg, prescribed off-label for weight loss): ~$936/month

According to a 2024 analysis by GoodRx, fewer than 30% of commercially insured Americans have pharmacy benefit plans that cover GLP-1 medications for weight management (as opposed to for type 2 diabetes, where coverage is more common).

Novo Nordisk and Eli Lilly patient savings programs explained

Insurance vs. Cash Pay: How to Decide

Choosing between pursuing insurance coverage and paying out of pocket is a financial and logistical decision that deserves honest analysis.

When to Pursue Insurance Coverage

Insurance coverage makes sense when:

You have a commercial (employer-sponsored) health plan that explicitly lists GLP-1s for obesity or weight management in its formulary
You have a BMI of 30 or above, OR a BMI of 27 or above with a qualifying condition (hypertension, type 2 diabetes, sleep apnea, etc.) — these are the standard FDA eligibility criteria
You're willing to invest time in the prior authorization process, which can take 2–8 weeks and may require an appeal

Key step: Before spending anything, call the member services number on the back of your insurance card and ask specifically: "Does my plan cover Wegovy or Zepbound for weight management? What are the requirements for prior authorization?"

Medicare Part D began covering Wegovy for cardiovascular risk reduction (not weight management broadly) following the SELECT trial results, which showed a 20% reduction in major cardiovascular events in patients with obesity and established cardiovascular disease. This is a meaningful but narrow coverage category.

When Cash Pay Makes More Sense

Cash pay — typically through a telehealth platform offering compounded semaglutide — makes sense when:

Your insurance doesn't cover GLP-1s for weight management
You want to start treatment quickly (cash pay programs can get medication to you in 5–10 days vs. weeks for insurance navigation)
Your out-of-pocket costs would be similar even with insurance (high-deductible plans)

Estimated monthly cash-pay cost comparison:

Option	Estimated Monthly Cost
Compounded semaglutide (telehealth)	$99–$399
Wegovy with Novo Nordisk savings card (commercially insured)	$0–$25
Wegovy without insurance	~$1,349
Zepbound with Eli Lilly savings card (commercially insured)	$25–$150
Zepbound without insurance	~$1,059

The math is clear: if you can access manufacturer savings programs through insurance, brand-name is far cheaper than the list price suggests. If you cannot, compounded semaglutide through a reputable telehealth platform is the most cost-effective option currently available.

Red Flags to Watch For

Not all GLP-1 telehealth programs are created equal. Some platforms cut corners in ways that could affect your safety or leave you paying for something that doesn't work as expected. Here's what to watch for.

Red Flag 1: No Real Medical Review

If a platform approves your prescription within minutes of a basic online quiz — with no back-and-forth with a licensed prescriber — that's a problem. Legitimate programs require a thorough health history, and many require lab work. A quick approval might feel convenient, but it means no one is actually checking whether GLP-1 therapy is safe for you specifically.

Red Flag 2: No Pharmacy Disclosure

You have a right to know where your medication is being compounded. If a platform refuses to tell you which pharmacy fills your prescription, or gives vague answers when you ask, treat that as a warning sign. Reputable platforms disclose their pharmacy partners and can provide a certificate of analysis upon request.

Red Flag 3: Prices That Seem Too Good to Be True

Compounded semaglutide at legitimate 503A pharmacies has real production costs. If a platform is offering compounded semaglutide at $50–$70/month, ask how that's possible. Low prices can indicate diluted formulations, ingredient substitution, or unregulated sourcing. The FDA has specifically warned about products marketed as "semaglutide" that contain salt forms of the compound (such as semaglutide sodium or acetate) rather than the active base form.

Red Flag 4: No Dosing Escalation Protocol

FDA-approved GLP-1 medications follow a gradual dose escalation — starting at a low dose and increasing over weeks or months. This is not just a regulatory formality; it significantly reduces gastrointestinal side effects. If a platform starts you at the full maintenance dose immediately, or has no documented titration protocol, that's a clinical concern.

Red Flag 5: No Pathway for Side Effect Management

Nausea, vomiting, constipation, and other GI effects are common, particularly in the early weeks. A legitimate program should have a clear process for patients to reach a clinician if side effects are severe — not just a FAQ page or a chatbot. Ask specifically: "What happens if I have significant side effects? Who do I contact, and how quickly will someone respond?"

Red Flag 6: Vague or Aggressive Marketing Claims

Be skeptical of platforms that promise specific weight loss numbers ("lose 30 pounds in 3 months"), use before/after imagery that isn't representative of typical results, or pressure you to sign up quickly. Evidence-based language looks like: "Clinical trials showed an average weight reduction of X% over Y weeks." It does not look like guaranteed outcomes.

Frequently Asked Questions

What is the cheapest legitimate online GLP-1 program in 2026?

The most affordable legitimate options for compounded semaglutide online currently start around $99–$129/month through platforms like Found or LifeMD. However, the cheapest overall option depends on your insurance situation — commercially insured patients who qualify for manufacturer savings programs can access brand-name Wegovy for as little as $0–$25/month. Always factor in consultation fees, lab costs, and shipping when comparing total monthly costs across platforms.

How do I know if an online GLP-1 program is legitimate?

A legitimate program will require a thorough medical intake process reviewed by a licensed prescriber (not just an automated quiz), disclose which licensed pharmacy compounds or dispenses the medication, follow a gradual dose escalation protocol, and have a clear process for managing side effects. Red flags include instant approvals, no pharmacy disclosure, and prices significantly below market rate for compounded semaglutide.

Is compounded semaglutide as effective as Wegovy?

Compounded semaglutide uses the same active ingredient as Wegovy (semaglutide), but it has not undergone the same clinical trials as the FDA-approved brand. When properly formulated from pharmaceutical-grade ingredients, clinical practitioners generally expect similar physiological effects. However, quality control varies across compounding pharmacies, and the FDA has warned about products sold as semaglutide that contain different compound forms. Brand-name Wegovy at 2.4 mg produced an average 14.9% weight reduction over 68 weeks in the STEP 1 trial.

Can I get an Ozempic prescription online for weight loss?

Technically, Ozempic (semaglutide 1.0 mg) is FDA-approved for type 2 diabetes management, not specifically for weight loss — Wegovy (semaglutide 2.4 mg) carries the weight management indication. However, healthcare providers can prescribe Ozempic off-label for weight management, and some telehealth platforms facilitate this. The more common and appropriate path for weight management is to pursue Wegovy (or compounded semaglutide) through a telehealth platform with a legitimate clinical process. Ozempic vs. Wegovy: what's the actual difference

What happens if I stop taking GLP-1 medication?

Research consistently shows that weight regains after discontinuing GLP-1 therapy without maintaining lifestyle changes. A 2022 study published in Diabetes, Obesity and Metabolism found that participants regained approximately two-thirds of the weight they had lost within one year of stopping semaglutide. This is why programs that integrate behavioral support alongside medication — like WeightWatchers/Sequence or Noom Med — emphasize habit formation during treatment, not just weight loss while on the drug. Speak with your healthcare provider about a long-term plan before you begin.

Methodology / Sources

How This Article Was Researched

The GLP-1 Guide Team evaluated each platform based on publicly available information, including pricing pages, terms of service, disclosed pharmacy partnerships, and published clinical protocols. Where platforms publish outcomes data, we referenced it with appropriate context. We also reviewed user feedback across multiple third-party platforms (app store reviews, Reddit communities, Trustpilot) to identify consistent patterns — though anecdotal reports are noted as such and not treated as clinical evidence.

No platform paid for placement or editorial review in this article. Rankings reflect our scoring framework applied consistently across all eight platforms. Affiliate relationships are disclosed per FTC guidelines and do not influence rankings.

Clinical Sources Referenced

STEP 1 Trial (2021): Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. DOI: 10.1056/NEJMoa2032183
- Key finding: 14.9% average body weight reduction over 68 weeks with semaglutide 2.4 mg
SURMOUNT-1 Trial (2022): Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. DOI: 10.1056/NEJMoa2206038
- Key finding: Up to 20.9% average weight reduction over 72 weeks with tirzepatide 15 mg
SELECT Trial (2023): Lincoff AM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." New England Journal of Medicine. DOI: 10.1056/NEJMoa2307563
- Key finding: 20% reduction in major cardiovascular events; basis for Medicare coverage expansion
Post-discontinuation weight regain study (2022): Wilding JPH, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide." Diabetes, Obesity and Metabolism. DOI: 10.1111/dom.14725
FDA MedWatch / FDA Drug Shortage Database: Referenced for semaglutide shortage resolution timeline and compounding pharmacy regulatory guidance
GoodRx Insurance Coverage Analysis (2024): Referenced for insurance coverage statistics

A Note on Accuracy

Pricing, platform offerings, and the regulatory landscape for compounded GLP-1 medications change frequently. We review and update this article on a rolling basis. The regulatory status of compounded semaglutide in particular is subject to ongoing FDA guidance — verify current status with your healthcare provider or directly with the telehealth platform before enrolling.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. GLP-1 medications are prescription drugs and require evaluation by a licensed medical professional to determine whether they are appropriate for you.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence or our scoring methodology.

-- The GLP-1 Guide Team

Quick Answer